Mar 17, 2026 06:56AM Olema Pharmaceuticals (OLMA) PT Lowered to $38 at Guggenheim

Mar 16, 2026 03:02PM Olema Pharmaceuticals (OLMA) PT Raised to $62 at Citi

Mar 16, 2026 10:14AM Stifel on Olema Pharmaceuticals (OLMA): 'Investors Seeking Clarity on persevERA Miss'

Mar 9, 2026 11:59AM Olema Pharmaceuticals (OLMA) PT Lowered to $38 at H.C. Wainwright

Mar 9, 2026 10:32AM TD Cowen on Olema Pharmaceuticals (OLMA): 'Pala's Profile And Data Support Phase IIIs, Despite persevERA Disappointment'

Mar 9, 2026 09:16AM Oppenheimer on Olema Pharmaceuticals (OLMA): "We think there’s more chapters to this story left to unfold"

Mar 9, 2026 08:41AM Stifel Reiterates Buy Rating on Olema Pharmaceuticals (OLMA): Roche Ph3 outcome "not optimal for OLMA stock near term"

Mar 9, 2026 07:34AM Stifel Suspects Olema Pharmaceuticals (OLMA) Holders 'may see today's sell-off as a buying opportunity'

Feb 10, 2026 04:06PM Stifel Starts Olema Pharmaceuticals (OLMA) at Buy

Jan 30, 2026 04:01PM Olema Oncology CFO Shane Kovacs to depart effective January 30

Jan 12, 2026 04:47PM Olema Pharmaceuticals reports cash exceeds $500 million at year-end

Jan 7, 2026 03:46AM Piper Sandler Starts Olema Pharmaceuticals (OLMA) at Overweight

Jan 7, 2026 12:49AM UBS Starts Olema Pharmaceuticals (OLMA) at Buy

Jan 6, 2026 06:11AM Citi Opens 90-Day Positive Catalyst Call on Olema Pharmaceuticals (OLMA)

Dec 12, 2025 05:54AM Olema Pharmaceuticals (OLMA) PT Raised to $60 at Citi, Opens Catalyst Watch

Dec 11, 2025 04:50PM Olema Pharmaceuticals (OLMA) files mixed shelf

Dec 11, 2025 06:42AM Olema Pharmaceuticals (OLMA) PT Raised to $45 at H.C. Wainwright

Dec 11, 2025 04:21AM Olema Pharmaceuticals (OLMA) PT Raised to $38 at Goldman Sachs

Dec 10, 2025 02:11PM Olema Pharmaceuticals (OLMA) PT Raised to $43 at Jefferies

Nov 18, 2025 09:34AM Olema Pharmaceuticals (OLMA) halted on volatility, up 167%

Oct 20, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Oct 8, 2025 05:35AM Guggenheim Starts Olema Pharmaceuticals (OLMA) at Buy

Sep 3, 2025 03:01PM Olema Pharmaceuticals (OLMA) latest collaboration could create future 'bidding war' - Oppenheimer

Sep 3, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Sep 2, 2025 07:03AM Olema Oncology partners with Pfizer for breast cancer drug trial

Aug 12, 2025 04:50AM Olema Pharmaceuticals (OLMA) PT Raised to $21 at Citi, Opens Catalyst Watch

Aug 11, 2025 04:56PM Olema Pharmaceuticals, Inc. (OLMA) Misses Q2 EPS by 13c

May 29, 2025 06:59AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

May 14, 2025 06:09AM Olema Pharmaceuticals (OLMA) PT Lowered to $28 at H.C. Wainwright

May 13, 2025 06:14PM Olema Pharmaceuticals, Inc. (OLMA) Tops Q1 EPS by 18c

Mar 19, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Mar 18, 2025 04:33PM Olema Pharmaceuticals, Inc. (OLMA) Tops Q4 EPS by 13c

Mar 6, 2025 07:25AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Jan 6, 2025 04:09PM Olema Pharmaceuticals (OLMA) Files $200M Mixed Shelf

Dec 23, 2024 05:18AM Olema Pharmaceuticals (OLMA) option IV near upper end of range

Dec 11, 2024 07:24AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Dec 2, 2024 07:33AM Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

Nov 26, 2024 08:56AM TD Cowen Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Oct 24, 2024 11:53AM Jefferies Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Oct 24, 2024 07:43AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Oct 24, 2024 06:16AM Goldman Sachs Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

Sep 10, 2024 05:17AM Goldman Sachs Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)